This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Pemphigoid
L12_PEMPHIGOID
bullous pemphigoid: Bullous pemphigoid (BP) is the most common form of autoimmune bullous dermatosis.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpoints |
1001 |
6. Filter based on genotype QC (FinnGen only) |
981 |
Control definitions (FinnGen only)
- Control exclude
- L12_BULLOUS
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- L10-L14
- Name in latin
- Pemphigoides
Similar endpoints
↥List of similar endpoints to
Pemphigoid
based on the number of shared cases.
Similar with more cases:
- Bullous disorders
- Autoimmune diseases
- Used for control exclusion in common control thyroid runs
- Diseases of the skin and subcutaneous tissue
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 981 | 495 | 486 |
| Unadjusted period prevalence (%) | 0.20 | 0.18 | 0.22 |
| Median age at first event (years) | 73.51 | 71.83 | 75.22 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1001
- Matched controls
- 10010
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
L12.0
ICD-10 Finland
Bullous pemphigoid
12466.9
307.7
784
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
13.8
307.7
484
635
D07AD01
ATC
clobetasol; topical
11.1
307.7
531
928
L12.9
ICD-10 Finland
Pemphigoid, unspecified
940.4
234.4
221
*
L30.9
ICD-10 Finland
Dermatitis, unspecified
6.2
174.2
435
1102
D07AC01
ATC
betamethasone; topical
6.0
168.5
663
2472
L13.9
ICD-10 Finland
Bullous disorder, unspecified
73.6
138.4
75
11
TQW80
NOMESCO Finland
Local dermatologic skincare
14.5
136.6
129
101
L04AX01
ATC
azathioprine; systemic
10.8
129.3
150
161
H02AB06
ATC
prednisolone; systemic
5.4
125.9
763
3722
E0000UV, ,
ATC
4.7
123.6
656
2880
L12.8
ICD-10 Finland
Other pemphigoid
+∞
117.0
110
*
J04BA02
ATC
dapsone; oral
140.2
96.0
101
8
L04AX03
ATC
methotrexate; systemic
5.6
95.9
213
463
ECA20
NOMESCO Finland
Biopsy of gingiva
19.4
78.3
62
34
L12.1
ICD-10 Finland
Cicatricial pemphigoid
+∞
76.0
72
*
XQ848
NOMESCO Finland
Dermatological photography
8.5
75.6
103
134
D07AC13
ATC
mometasone; topical
3.2
70.0
424
1847
L12
ICD-10 Finland
Pemphigoid
242.9
67.1
68
*
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
3.9
64.0
232
726
135
Kela drug reimbursment
Pemphigus
+∞
58.9
56
*
L29.9
ICD-10 Finland
Pruritus, unspecified
7.5
54.5
81
116
D07AB08
ATC
desonide; topical
3.7
52.8
193
602
D07BC01
ATC
betamethasone and antiseptics; topical
3.5
50.0
203
677
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.6
47.6
513
2886
E000001, ,
ATC
2.8
43.6
274
1170
L12.2
ICD-10 Finland
Chronic bullous disease of childhood
+∞
40.9
39
*
D07AB02
ATC
hydrocortisone butyrate; topical
2.5
40.8
375
1924
L29.8
ICD-10 Finland
Other pruritus
9.1
34.8
43
49
A10BH05
ATC
linagliptin; oral
3.7
34.1
119
355
L04AA06
ATC
mycophenolic acid; systemic
9.3
33.5
41
46
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.6
33.3
234
1042
D02AX
ATC
Other emollients and protectives
6.2
32.9
58
99
D09AB01
ATC
zinc bandage without supplements; topical
6.6
32.3
53
84
SBB00
NOMESCO Finland
Clinical photography of mouth and teeth
5.6
30.5
59
110
R06AE07
ATC
cetirizine; oral
2.1
29.7
448
2747
K13.79
ICD-10 Finland
Change in the oral mucosa UNS
5.6
29.3
57
107
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
4.4
28.9
75
180
A02BC02
ATC
pantoprazole; systemic
2.3
28.6
741
5560
S99
ICPC
Skin disease other
5.6
27.4
53
99
L30.3
ICD-10 Finland
Infective dermatitis
4.7
26.7
64
144
S29
ICPC
Skin symptom/complaint other
2.3
26.5
241
1196
EKA10
NOMESCO Finland
iopsy of buccal mucosa
5.6
26.4
51
95
L30.0
ICD-10 Finland
Nummular dermatitis
4.3
26.2
70
172
A10AB05
ATC
insulin aspart; parenteral
3.0
26.1
124
446
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
4.0
26.0
78
209
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.5
25.9
187
836
R06AX27
ATC
desloratadine; oral
2.3
25.8
257
1325
L28.1
ICD-10 Finland
Prurigo nodularis
10.6
25.4
28
27
J01DB01
ATC
cefalexin; oral
2.5
25.4
833
6693
A46
ICD-10 Finland
Erysipelas
2.4
25.3
219
1062
SBA00
NOMESCO Finland
Microbiological examinations
5.5
25.2
49
92
S18
ICPC
Laceration/cut
2.0
24.6
520
3530
215
Kela drug reimbursment
Diabetes, non-insulin-treated
2.1
23.9
311
1774
D07BA04
ATC
hydrocortisone and antiseptics; topical
2.8
23.2
128
499
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
2.3
22.8
202
985
S97
ICPC
Chronic ulcer skin
2.9
22.5
112
413
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.0
20.7
290
1685
L13.0
ICD-10 Finland
Dermatitis herpetiformis
214.3
20.6
21
*
A10AE04
ATC
insulin glargine; parenteral
2.5
19.9
139
607
K13.78
ICD-10 Finland
Other change in the oral mucosa
5.4
19.5
39
75
T90
ICPC
Diabetes non-insulin dependent
1.9
18.8
297
1789
C03CA01
ATC
furosemide; systemic
1.8
18.4
474
3326
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
2.3
18.3
161
778
D02AE01
ATC
carbamide; topical
2.9
18.0
89
326
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.8
18.0
538
3935
L10.9
ICD-10 Finland
Pemphigus, unspecified
+∞
17.8
17
*
L12.3
ICD-10 Finland
Acquired epidermolysis bullosa
+∞
17.8
17
*
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
5.2
17.7
37
74
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.9
17.3
325
2062
A28
ICPC
Limited function/disability NOS
1.9
17.2
273
1641
XQ802
NOMESCO Finland
Epicutan test
4.0
16.8
48
124
103
Kela drug reimbursment
Diabetes, insulin-treated
1.8
16.7
341
2214
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
4.0
15.9
46
120
H02AB09
ATC
hydrocortisone; systemic
4.3
15.7
41
99
L89
ICD-10 Finland
Decubitus ulcer and pressure area
4.1
15.6
43
108
L30.8
ICD-10 Finland
Other specified dermatitis
4.4
15.6
39
91
J45.9
ICD-10 Finland
Asthma, unspecified
1.9
15.6
221
1274
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
2.4
15.5
112
495
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
2.8
15.4
82
312
H02AB07
ATC
prednisone; oral
2.1
15.4
178
954
B86
ICD-10 Finland
Scabies
5.7
15.1
28
50
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
2.5
15.1
97
406
L13.8
ICD-10 Finland
Other specified bullous disorders
45.7
15.1
18
*
A10BA02
ATC
metformin; oral
1.8
14.9
348
2335
SAA03
NOMESCO Finland
Extended examination of mouth
1.8
14.9
341
2275
H13.3*L12.9
ICD-10 Finland
Ocular pemphigoid
+∞
14.6
14
*
SPAT1229
SPAT
Assessment of need for aid
2.3
14.6
122
575
J01FF01
ATC
clindamycin; systemic
1.8
14.6
285
1814
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
2.3
14.6
115
529
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.6
14.0
82
328
E000003, ,
ATC
3.2
13.8
57
188
WXQ27
NOMESCO Finland
UVB narrow spectrum light therapy
6.3
13.8
23
37
S17
ICPC
Abrasion/scratch/blister
4.0
13.6
39
101
E86
ICD-10 Finland
Volume depletion
3.4
13.6
49
149
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.8
13.5
250
1561
ZY010
NOMESCO Finland
Hospital outpatient
3.3
13.4
51
160
R06AE09
ATC
levocetirizine; oral
2.1
13.4
134
678
S21
ICPC
Skin texture symptom/complaint
2.0
13.4
157
843
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.7
13.4
322
2167
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.8
13.3
243
1509
L20.0
ICD-10 Finland
Besnier prurigo
3.0
13.3
58
198
SPAT1262
SPAT
Handing over of treatment supplies
1.9
13.3
212
1264
J01CF05
ATC
flucloxacillin; systemic
2.6
13.2
76
302
S02
ICPC
Pruritus
3.1
13.1
54
178
K12.10
ICD-10 Finland
Stomatitis NOS
15.3
13.1
21
14
D07AA02
ATC
hydrocortisone; topical
2.1
13.1
143
749
SPAT1172
SPAT
Guidance concerning hydration
3.4
13.0
46
138
SPAT1254
SPAT
Administration of medicine
1.9
12.9
193
1125
L50.9
ICD-10 Finland
Urticaria, unspecified
3.5
12.5
42
122
A10AC01
ATC
insulin (human); parenteral
2.2
12.3
106
506
L10.0
ICD-10 Finland
Pemphigus vulgaris
121.4
11.4
12
*
N08.39*E11.2
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic nephropathy
4.2
11.4
30
73
I83.0
ICD-10 Finland
Varicose veins of lower extremities with ulcer
3.3
11.3
43
135
SPAT1153
SPAT
Removal of sutures
1.6
11.3
339
2394
E000002, ,
ATC
2.1
11.1
106
527
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
2.7
11.0
58
220
L40.0
ICD-10 Finland
Psoriasis vulgaris
3.1
11.0
47
159
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
1.9
10.9
144
804
L43.8
ICD-10 Finland
Other lichen planus
4.0
10.9
31
80
AA1AD
NOMESCO Finland
CT of head and brain
1.6
10.7
327
2315
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.7
10.5
200
1250
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.6
10.5
362
2635
L51.19
ICD-10 Finland
Other bullous erythema multiforme
111.1
10.4
11
*
L10.2
ICD-10 Finland
Pemphigus foliaceus
+∞
10.4
10
*
A10BH02
ATC
vildagliptin; oral
3.3
10.2
38
118
R60.0
ICD-10 Finland
Localized oedema
1.9
10.1
151
876
I10
ICD-10 Finland
Essential (primary) hypertension
1.6
10.0
681
5747
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.8
9.9
171
1038
R53
ICD-10 Finland
Malaise and fatigue
1.6
9.8
261
1781
SPAT1167
SPAT
Insertion of urinary catheter
2.6
9.5
54
213
C07AB07
ATC
bisoprolol; oral
1.5
9.5
565
4604
J01MA02
ATC
ciprofloxacin; systemic
1.5
9.5
412
3140
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.6
9.4
312
2237
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.7
9.4
176
1091
L43.1
ICD-10 Finland
Bullous lichen planus
30.3
9.4
12
*
E11
ICD-10 Finland
Type 2 diabetes mellitus
1.7
9.4
180
1125
E000006, ,
ATC
2.2
9.3
78
367
XQ800
NOMESCO Finland
Prick test
2.5
9.3
60
252
N18.8
ICD-10 Finland
Other chronic renal failure
2.9
9.2
42
148
A10BH01
ATC
sitagliptin; oral
1.9
9.1
119
661
A07AA02
ATC
nystatin; oral
2.2
9.1
78
371
RS222, ,
NOMESCO Finland
4.6
9.1
21
46
K12.00
ICD-10 Finland
Recurrent oral aphthae
4.8
9.1
20
42
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.6
9.1
311
2245
N02BE01
ATC
paracetamol; systemic, rectal
1.8
9.0
865
7815
E000007, ,
ATC
2.5
9.0
56
231
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.6
9.0
319
2318
EBA15
NOMESCO Finland
Extraction of multiple teeth
2.7
9.0
47
178
SPAT1263
SPAT
Sampling
1.5
8.9
409
3143
M05BA04
ATC
alendronic acid; oral
1.9
8.7
125
715
G63.2*E11.4
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy
4.3
8.7
22
52
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.8
8.7
126
724
SPAT1310
SPAT
Counselling related to known health issue
1.5
8.7
300
2166
SPAT1234
SPAT
Support of social functional capacity
2.2
8.7
76
365
SPAT1216
SPAT
Assessment of functional ability
1.6
8.7
206
1361
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.8
8.6
141
841
L20.9
ICD-10 Finland
Atopic dermatitis, unspecified
3.2
8.6
34
110
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
3.0
8.6
37
126
WZC00
NOMESCO Finland
Treatment plan or consultation
1.5
8.6
316
2313
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
2.8
8.5
42
154
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
2.3
8.5
66
301
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.5
8.5
353
2649
A98
ICPC
Health maint/preventive medicine
1.8
8.4
889
8133
A04
ICPC
Weakness/tiredness general
1.7
8.4
166
1044
L10.8
ICD-10 Finland
Other pemphigus
+∞
8.3
8
*
D07CC01
ATC
betamethasone and antibiotics; topical
1.8
8.3
126
733
S76
ICPC
Skin infection other
2.3
8.3
61
272
L43.9
ICD-10 Finland
Lichen planus, unspecified
3.4
8.3
29
87
Z2221
NOMESCO Finland
Medical doctor
1.6
8.2
265
1881
L21.8
ICD-10 Finland
Other seborrhoeic dermatitis
4.4
8.2
20
46
WX110
NOMESCO Finland
Infiltration anesthesia
1.5
8.1
600
5036
L28
ICPC
Limited function/disability (L)
1.6
8.0
223
1527
C08CA01
ATC
amlodipine; oral
1.5
8.0
436
3445
205
Kela drug reimbursment
Chronic hypertension
1.5
8.0
349
2641
S32.0
ICD-10 Finland
Fracture of lumbar vertebra
2.5
7.8
49
204
I50.9
ICD-10 Finland
Heart failure, unspecified
1.6
7.7
217
1489
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.1
7.6
75
377
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.6
7.6
204
1385
K13.74
ICD-10 Finland
Lichen rubs planus in the mouth
3.9
7.3
21
55
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
1.8
7.2
117
695
L04AD01
ATC
ciclosporin; systemic
4.0
7.2
20
51
SPAT1125
SPAT
Stoma care and guidance
3.2
7.2
28
90
J01AA07
ATC
tetracycline; systemic
1.8
7.2
117
696
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.6
7.2
195
1327
C03AA03
ATC
hydrochlorothiazide; oral
1.8
7.1
121
728
Z3231
NOMESCO Finland
Registered nurse
1.5
7.1
270
1976
SPAT1301
SPAT
No procedures
1.5
7.1
324
2461
L29
ICD-10 Finland
Pruritus
4.2
7.0
18
43
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.7
7.0
139
875
D01AC02
ATC
miconazole; topical
1.9
6.9
85
462
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
2.0
6.9
72
370
J46
ICD-10 Finland
Status asthmaticus
2.9
6.9
32
114
D64.9
ICD-10 Finland
Anaemia, unspecified
1.7
6.9
136
854
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
2.0
6.8
70
358
I83.1
ICD-10 Finland
Varicose veins of lower extremities with inflammation
2.8
6.8
32
115
NHQ40
NOMESCO Finland
Amputation of toe
3.1
6.7
27
89
Z43.5
ICD-10 Finland
Attention to cystostomy
5.9
6.6
17
29
F03
ICD-10 Finland
Unspecified dementia
2.0
6.6
71
369
L03.9
ICD-10 Finland
Cellulitis, unspecified
3.2
6.6
25
79
S81.9
ICD-10 Finland
Open wound of lower leg, part unspecified
4.2
6.6
17
41
H04.10
ICD-10 Finland
Dry eye syndrome
1.8
6.5
101
591
TDM10
NOMESCO Finland
Puncture of maxillary antrum
2.6
6.5
37
147
D05BB02
ATC
acitretin; oral
3.1
6.5
26
85
J01AA04
ATC
lymecycline; systemic
1.8
6.5
101
593
E87.5
ICD-10 Finland
Hyperkalaemia
2.9
6.5
30
107
QCA99
NOMESCO Finland
Other local destruction of skin of upper limb
14.4
6.4
10
7
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
2.3
6.4
46
204
N18.0
ICD-10 Finland
End-stage renal disease
3.8
6.4
19
51
SPAT1305
SPAT
Counselling and guidance related to physical exercise
1.8
6.4
102
604
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.5
6.3
213
1516
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
1.7
6.3
125
785
M81.4
ICD-10 Finland
Drug-induced osteoporosis
11.1
6.3
11
10
L50.3
ICD-10 Finland
Dermatographic urticaria
3.9
6.3
18
47
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
2.6
6.3
34
132
4047, ,
NOMESCO Finland
+∞
6.3
6
*
K05.12
ICD-10 Finland
Gingivitis (chronic) simple marginal
26.8
6.2
8
*
B35.3
ICD-10 Finland
Tinea pedis
2.4
6.2
41
175
J45
ICD-10 Finland
Asthma
1.8
6.2
90
518
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.7
6.2
122
766
A29
ICPC
General symptom/complaint other
1.6
6.1
138
896
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.6
6.1
151
1003
N30.0
ICD-10 Finland
Acute cystitis
1.6
6.1
155
1036
A10AE05
ATC
insulin detemir; parenteral
2.1
6.1
57
282
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
2.5
6.1
36
146
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.5
6.0
180
1248
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
1.8
6.0
81
455
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
2.6
6.0
33
129
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
514
52
202.12
307.65
3.0
1.2
31.65
15.40
u/ml
—
300
5
370
46
127.01
307.65
1.7
1.1
58.40
55.71
titre
—
25
7
646
3644
3.18
66.84
10.8
5.4
3.20
2.82
%
2.98
620
3381
652
3728
3.15
65.26
11.1
5.6
24.33
26.10
%
3.74
625
3467
642
3666
3.09
63.88
10.7
5.4
60.00
58.58
%
2.30
618
3413
731
4534
3.27
61.99
12.3
8.4
4.57
4.27
e9/l
2.57
674
3946
217
678
3.81
59.67
2.6
2.0
349.96
379.13
nmol/l
1.21
199
609
150
371
4.58
56.52
1.3
1.2
585.14
178.40
u/ml
4.02
141
335
58
8
76.67
51.61
1.1
1.0
—
—
—
0
0
572
3885
2.10
28.55
5.1
4.6
33.68
34.62
g/l
3.52
520
3581
238
1153
2.40
27.81
3.4
2.4
1.93
1.78
%
1.42
218
1021
397
2407
2.08
26.34
2.7
2.2
3.12
3.16
mg/l
0.09
347
2029
611
4401
2.00
24.19
7.0
6.7
1.21
1.21
mmol/l
0.83
511
3712
187
861
2.44
24.18
3.5
2.5
74.84
68.09
e9/l
1.63
147
678
274
1483
2.17
24.15
1.3
1.2
1.12
1.50
u/ml
0.47
80
360
38
59
6.66
23.59
1.3
1.3
—
—
—
0
0
788
6260
2.22
23.42
9.2
7.4
82.60
80.84
u/l
0.28
750
5813
48
99
5.04
22.21
1.8
1.6
—
—
—
0
0
659
4958
1.96
21.97
5.3
4.8
7.33
6.83
mmol/l
4.58
623
4674
744
5870
2.04
21.21
5.1
4.1
16.08
14.60
mm/h
1.63
695
5313
595
4372
1.89
20.78
6.2
5.9
12.10
12.27
umol/l
0.08
560
4134
172
815
2.34
20.63
1.5
2.7
65.94
65.92
g/l
0.01
159
731
495
3445
1.86
20.37
15.2
10.0
0.00
0.00
e9/l
1.08
413
2813
254
1461
1.99
18.34
3.0
2.5
11.87
12.11
umol/l
0.23
239
1345
549
4031
1.80
18.20
6.4
5.8
1.21
1.21
mmol/l
0.44
490
3640
355
2289
1.85
18.09
1.8
1.6
19.06
20.45
nmol/l
0.89
301
1918
519
3755
1.79
18.02
2.5
2.1
95.75
92.99
pmol/l
0.60
284
1915
26
36
7.39
17.86
1.0
1.2
—
—
—
0
0
469
3320
1.78
17.31
3.4
2.8
140.46
146.90
ug/l
0.25
425
2994
466
3295
1.78
17.25
2.6
2.2
80.52
78.43
nmol/l
0.73
414
2849
232
1324
1.98
16.98
1.5
1.4
2.96
2.61
g/l
1.43
149
758
74
255
3.05
16.68
1.6
2.6
0.00
0.00
g/l
-0.00
69
234
74
258
3.02
16.34
1.6
2.6
0.00
0.00
g/l
-0.00
69
235
877
7631
2.20
15.44
26.0
17.2
25.35
26.67
mg/l
0.65
773
6273
573
4385
1.72
15.31
20.5
19.7
1.34
1.36
inr
0.13
147
1257
689
5554
1.77
15.23
6.3
5.1
5641.42
2509.01
e6/l
0.49
12
104
27
23
12.03
15.12
1.8
1.1
8.68
9.44
ug/l
0.34
27
23
157
812
2.11
14.92
5.6
6.6
11.58
11.28
mmol/l
0.18
144
768
74
272
2.86
14.87
1.6
2.6
0.00
0.02
g/l
0.59
69
248
309
2005
1.78
14.85
2.0
1.8
1240.57
1205.03
nmol/l
0.25
231
1481
77
298
2.72
14.04
1.6
2.4
38.22
36.67
g/l
1.47
70
255
87
360
2.55
13.88
1.6
2.5
9.72
10.70
g/l
1.47
80
316
186
1051
1.95
13.76
4.0
3.7
240.01
253.94
u/l
0.61
173
983
422
3036
1.67
13.70
3.5
3.2
2213.72
1828.34
ng/l
0.67
364
2645
168
919
2.00
13.64
2.3
2.8
8.61
9.81
umol/l
0.23
147
797
153
815
2.04
13.36
2.3
2.1
0.20
0.20
g/l
0.03
140
764
202
1192
1.87
13.04
5.6
5.1
1.05
1.03
mmol/l
0.40
178
1092
212
1271
1.85
13.02
3.0
2.5
21.68
21.71
%
0.01
176
1074
78
318
2.58
12.83
1.6
2.8
0.28
1.38
g/l
3.02
69
270
83
350
2.50
12.73
1.6
2.5
2.93
3.09
g/l
0.92
76
307
88
382
2.43
12.68
1.6
2.5
3.70
3.55
g/l
0.55
81
340
88
383
2.42
12.61
1.6
2.5
7.13
7.57
g/l
1.94
81
340
88
383
2.42
12.61
1.6
2.5
—
—
—
0
0
897
8011
2.15
12.57
29.3
20.6
138.88
139.54
mmol/l
8.33
877
7768
64
240
2.78
12.40
1.2
1.2
0.28
1.56
u/ml
—
5
19
218
1341
1.80
12.24
3.0
2.5
2.24
2.27
g/l
0.35
206
1230
897
8028
2.13
12.23
29.5
20.8
4.01
4.00
mmol/l
0.33
876
7775
822
7150
1.84
12.15
7.9
6.4
42.74
40.87
mmol/mol
5.27
761
6479
895
8008
2.11
12.14
17.5
10.9
24.10
24.17
u/l
0.04
872
7645
432
3213
1.61
11.76
4.0
3.4
—
—
—
0
0
361
2587
1.62
11.36
3.4
3.2
253.21
333.79
mg/l
0.17
253
1656
248
1630
1.69
10.88
2.0
1.8
—
—
—
0
0
375
2745
1.59
10.63
4.1
3.7
16.25
9.23
mg/mmol
0.75
263
1738
837
7432
1.77
10.09
5.6
5.0
6.25
6.08
mmol/l
2.63
768
6602
681
5742
1.58
10.08
4.2
3.9
15.24
15.08
pmol/l
0.89
617
5058
362
2654
1.57
10.07
3.7
3.1
6.65
7.03
mmol/l
1.08
302
2170
799
7008
1.69
10.03
5.3
4.8
2.03
2.18
mu/l
0.39
733
6227
907
8264
2.04
10.00
39.2
25.3
38.60
39.13
%
1.79
829
7581
562
4545
1.54
9.99
3.9
3.1
65.87
52.89
u/l
1.82
515
4125
907
8265
2.04
9.98
39.5
25.2
246.43
240.99
e9/l
1.52
889
8001
907
8266
2.04
9.96
39.4
25.2
4.26
4.37
e12/l
8.10
888
7967
907
8268
2.03
9.92
39.8
25.3
128.58
131.93
g/l
8.90
892
8088
55
217
2.62
9.69
1.6
1.5
1.15
25.62
iu/ml
—
10
47
93
464
2.11
9.62
1.9
1.9
1.51
1.57
g/l
0.21
80
404
160
969
1.78
9.29
4.6
3.7
—
—
—
0
0
328
2389
1.55
9.22
3.2
3.0
47.17
34.46
u/l
0.70
308
2265
350
2593
1.54
9.08
3.1
2.4
66.88
91.95
u/l
0.36
316
2379
401
3060
1.52
9.06
3.4
3.3
2.35
2.35
mmol/l
0.12
340
2637
450
3520
1.51
9.02
5.0
4.2
157.95
54.66
ng/l
0.46
373
2703
493
3940
1.50
8.84
4.8
4.2
0.00
0.00
estimate
-0.00
82
727
489
3904
1.49
8.80
4.7
4.2
0.01
0.00
estimate
0.42
96
810
356
2663
1.52
8.77
2.7
2.1
200.72
234.75
u/l
0.36
333
2486
46
176
2.69
8.63
1.3
1.2
7.91
2.55
u/ml
—
9
27
837
7524
1.69
8.51
5.2
5.3
2.47
2.57
mmol/l
2.67
761
6746
208
1388
1.63
8.38
2.8
3.0
0.81
0.82
mmol/l
0.55
183
1283
45
173
2.68
8.37
1.4
1.2
11.77
2.94
u/ml
—
6
19
484
3886
1.48
8.29
6.4
5.7
0.00
0.00
estimate
-0.00
89
739
69
326
2.20
8.20
2.6
2.2
695.37
548.00
ug/l
0.16
62
307
814
7318
1.60
7.67
4.7
4.7
4.39
4.46
mmol/l
1.03
737
6601
100
561
1.87
7.42
2.8
2.7
10.60
11.06
g/l
0.44
93
509
142
885
1.70
7.39
3.5
3.5
1.67
2.10
mmol/l
0.61
123
724
463
3747
1.44
7.28
2.5
2.5
—
—
—
0
0
274
2004
1.51
7.26
2.0
1.8
32432871.32
9770200.95
pmol/l
0.31
222
1607
168
1104
1.63
7.12
4.6
6.8
1.12
1.33
mmol/l
0.27
115
870
203
1396
1.57
7.12
1.7
1.9
29.81
29.95
s
0.13
198
1349
142
894
1.69
7.11
3.5
3.5
5.91
5.82
kpa
0.45
136
866
131
807
1.72
7.11
4.2
6.7
1.60
1.43
mmol/l
1.15
124
787
728
6430
1.48
7.02
32.2
20.3
15.28
15.37
%
0.18
719
6306
391
3087
1.44
6.94
4.7
4.0
169.64
124.20
e6/l
0.38
288
2290
350
2714
1.45
6.81
4.2
3.5
324.87
99.65
e6/l
0.40
275
2152
788
7111
1.51
6.49
24.5
16.3
69.56
72.69
ml/min/173m2
3.31
680
5880
137
877
1.65
6.43
2.3
2.5
5.37
6.28
ug/l
0.36
109
750
165
1106
1.59
6.42
4.7
6.7
5.02
5.08
kpa
0.38
149
1054
165
1107
1.59
6.39
4.7
6.7
12.03
11.68
kpa
0.28
149
1056
799
7238
1.51
6.39
4.6
4.6
1.44
1.45
mmol/l
0.37
720
6465
120
745
1.69
6.32
3.0
2.9
4.42
4.43
kpa
0.02
113
719
171
1160
1.57
6.32
1.9
1.7
—
—
—
0
0
231
1673
1.49
6.31
1.6
1.7
1.47
1.40
mg/l
0.18
182
1308
170
1164
1.55
6.02
1.9
1.8
—
—
—
0
0
94
553
1.77
5.99
1.7
1.5
—
—
—
0
0
77
430
1.86
5.82
4.3
3.7
23.32
24.11
mmol/l
0.94
72
421
103
628
1.71
5.80
1.7
1.6
—
—
—
0
0
117
739
1.66
5.78
3.7
3.8
120.05
93.49
ng/l
1.33
100
631
317
2475
1.41
5.75
4.0
3.4
0.48
0.53
e6/l
0.25
249
1943
93
556
1.74
5.62
4.8
4.1
1.91
1.97
mmol/l
0.05
67
418
97
591
1.71
5.48
4.8
4.0
5.34
5.18
kpa
0.92
91
571
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
63
338
1.92
5.39
2.4
2.5
0.37
0.36
u/ml
0.07
35
199
453
3781
1.36
5.39
2.9
2.7
—
—
—
0
0
73
413
1.83
5.31
2.2
1.8
1.39
3.15
ug/l
0.69
61
353
768
6986
1.43
5.26
4.2
4.1
1.30
1.26
mmol/l
0.98
687
6173
269
2068
1.41
5.26
4.3
4.0
85.45
84.97
%
0.11
262
2020
277
2142
1.41
5.23
3.4
2.8
6010.48
8614.50
umol/l
0.40
240
1810
35
152
2.35
5.15
1.2
1.2
—
—
—
0
0
205
1515
1.44
4.96
3.0
3.0
1.53
1.35
e6/l
0.18
117
899
108
699
1.61
4.85
1.8
1.6
—
—
—
0
0
45
224
2.06
4.78
1.5
1.6
—
—
—
0
0
67
383
1.80
4.74
1.8
1.8
—
—
—
0
0
195
1442
1.44
4.68
3.3
3.2
3.13
2.31
e6/l
0.51
109
832
231
1775
1.39
4.45
5.7
4.1
189.11
279.85
ng/l
0.52
203
1524
79
484
1.69
4.41
4.8
9.3
24.10
24.62
mmol/l
0.96
69
466
20
71
2.85
4.40
1.0
1.0
1.48
1.70
u/ml
—
5
23
33
151
2.23
4.34
5.3
3.9
0.48
1.52
%
2.14
27
129
61
349
1.80
4.32
1.7
1.6
—
—
—
0
0
32
149
2.19
4.06
3.8
3.1
62.47
60.31
%
0.45
32
149
58
335
1.78
4.00
2.6
3.3
44.87
76.83
mg/l
0.85
44
265
34
164
2.11
3.96
1.3
1.3
—
—
—
0
0
58
337
1.77
3.93
2.6
3.3
30.77
51.54
mg/l
1.14
44
270
23
95
2.45
3.82
8.2
3.3
55.59
54.61
%
0.09
17
79
39
201
1.98
3.82
3.2
2.1
125.33
126.52
g/l
0.14
33
149
28
127
2.24
3.79
1.2
1.2
—
—
—
0
0
59
350
1.73
3.73
5.2
4.9
24.92
24.95
mmol/l
0.03
54
328
24
103
2.36
3.69
1.3
1.3
117.89
102.75
u/ml
—
7
16
11
25
4.44
3.63
2.2
2.4
57090.91
39252.20
ug/l
0.62
11
25
30
144
2.12
3.56
3.8
2.8
5.31
4.56
e9/l
0.81
30
144
222
1753
1.34
3.54
5.7
4.6
1.01
1.02
kg/l
0.71
33
254
146
1080
1.41
3.48
10.1
8.5
—
—
—
0
0
16
58
2.79
3.43
1.1
1.1
—
—
—
0
0
232
1854
1.33
3.40
3.4
3.0
2.47
2.46
mmol/l
0.94
203
1621
241
1942
1.32
3.33
3.4
2.6
6.90
4.99
e6/l
1.01
224
1757
15
54
2.80
3.26
1.1
1.1
—
—
—
0
0
15
54
2.80
3.26
1.1
1.1
—
—
—
0
0
353
3001
1.27
3.22
5.4
4.5
—
—
—
0
0
15
55
2.75
3.16
1.1
1.1
—
—
—
0
0
15
55
2.75
3.16
1.1
1.1
—
—
—
0
0
15
55
2.75
3.16
1.1
1.1
—
—
—
0
0
265
2177
1.30
3.16
5.3
4.4
0.00
0.00
estimate
0.50
80
703
13
41
3.20
3.06
1.5
2.1
—
—
—
0
0
107
768
1.44
3.02
2.6
2.1
224.58
148.29
ug/g
0.64
85
596
245
2007
1.29
2.97
2.6
2.4
—
—
—
0
0
90
627
1.48
2.96
1.6
1.7
1.65
1.57
%
0.33
70
514
6
9
6.70
2.87
1.0
1.2
98.83
78.78
%
—
6
9
86
598
1.48
2.87
3.2
3.1
122.23
125.15
g/l
0.69
86
585
104
760
1.41
2.68
5.0
3.6
1.23
1.22
mmol/l
0.57
96
651
12
42
2.88
2.55
1.8
1.7
1.86
4.37
u/field
—
7
27
14
56
2.52
2.54
1.6
1.2
—
—
—
0
0
67
455
1.51
2.53
2.1
2.5
—
25.69
—
0
23
88
631
1.43
2.53
5.3
2.9
58.49
58.82
ml/min/173m2
0.03
41
271
70
483
1.48
2.45
3.7
3.3
25.75
25.27
mmol/l
0.54
70
466
102
760
1.38
2.37
3.0
2.3
45.30
35.88
u/l
0.25
89
642
7
17
4.14
2.36
1.9
1.6
—
—
—
0
0
45
285
1.61
2.32
3.8
3.3
0.77
0.86
nmol/l
1.01
36
226
28
156
1.82
2.27
1.3
2.1
60.90
61.36
%
0.03
28
156
6
13
4.64
2.27
1.5
1.1
—
—
—
0
0
22
115
1.93
2.17
1.2
1.2
—
—
—
0
0
34
207
1.67
2.06
1.4
1.3
—
—
—
0
0
34
207
1.67
2.06
1.4
1.3
—
—
—
0
0
51
345
1.50
2.01
2.4
2.9
—
—
—
0
0
10
38
2.65
2.00
1.1
1.1
—
—
—
0
0
46
305
1.53
1.99
1.2
1.2
—
—
—
0
0
20
107
1.89
1.87
1.5
1.5
77.27
65.19
%
0.91
15
73
15
72
2.10
1.87
2.0
1.3
11.13
14.44
u/l
1.45
15
66
7
23
3.06
1.80
1.3
1.1
76.17
133.56
iu/ml
—
7
23
20
109
1.85
1.78
1.2
1.2
314.43
308.41
u/ml
0.02
14
61
39
258
1.53
1.73
1.4
1.6
—
—
—
0
0
6
19
3.17
1.66
1.0
1.2
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
6
19
3.17
1.66
2.7
2.5
213.67
143.26
%
—
6
19
336
3015
1.17
1.58
4.9
5.6
5.66
3.65
ug/l
0.27
304
2645
25
152
1.66
1.57
1.2
1.3
0.97
0.88
nmol/l
0.23
17
124
11
50
2.21
1.57
1.3
1.3
—
—
—
0
0
11
50
2.21
1.57
1.3
1.3
—
—
—
0
0
113
916
1.26
1.51
3.9
3.1
220.84
245.57
ng/l
0.32
102
844
12
59
2.05
1.44
2.5
2.1
58.60
89.10
ug/min
—
5
10
31
206
1.52
1.39
1.7
2.4
3.72
3.68
g/l
0.06
25
195
12
60
2.01
1.38
1.4
1.1
250.00
99.09
titre
—
6
11
9
41
2.21
1.37
1.0
1.2
—
—
—
0
0
5
17
2.95
1.36
1.4
1.5
64.20
104.76
nmol/24h
—
5
17
32
217
1.49
1.32
1.5
1.4
—
—
—
0
0
15
83
1.82
1.31
1.1
2.0
—
—
—
0
0
37
259
1.45
1.31
1.5
1.4
267.35
276.46
ug/g
0.07
17
149
6
24
2.51
1.30
1.0
1.7
3.75
9.92
nmol/l
—
6
18
5
18
2.79
1.28
2.6
1.7
—
—
—
0
0
136
1149
1.21
1.27
1.3
1.3
27.80
37.88
iu/ml
0.57
48
366
9
44
2.05
1.27
4.7
4.2
—
—
—
0
0
104
856
1.24
1.25
1.4
1.4
—
—
—
0
0
5
19
2.64
1.21
1.2
1.0
1415.60
1673.16
miu/ml
—
5
19
6
26
2.32
1.19
1.8
4.3
13.50
13.50
%
—
6
26
50
377
1.34
1.18
2.7
3.0
4.15
4.41
pmol/l
1.02
41
324
7
30
2.34
1.12
2.4
1.9
532.57
2018.70
u/ml
—
7
30
7
31
2.27
1.10
1.0
1.0
—
—
—
0
0
61
481
1.29
1.07
1.9
2.2
10.80
11.84
nmol/l
0.43
52
410
10
52
1.93
1.06
3.1
4.7
—
—
—
0
0
36
263
1.38
1.05
2.4
1.6
—
—
—
0
0
16
99
1.63
1.00
1.6
1.5
—
—
—
0
0
27
189
1.44
1.00
1.3
1.4
—
—
—
0
0
9
49
1.84
0.98
1.8
1.5
—
—
—
0
0
30
215
1.41
0.98
1.8
2.3
73.24
108.85
ug/min
0.38
15
131
7
36
1.95
0.97
1.4
1.2
—
—
—
0
0
11
62
1.78
0.94
1.5
1.3
—
—
—
0
0
11
62
1.78
0.94
1.5
1.3
—
—
—
0
0
92
779
1.20
0.89
1.5
1.4
—
—
—
0
0
10
56
1.79
0.88
2.4
2.5
—
—
—
0
0
22
154
1.44
0.84
1.7
1.6
1.58
5.14
iu/l
—
5
48
8
46
1.74
0.82
1.5
2.1
—
—
—
0
0
16
105
1.53
0.82
1.3
1.4
—
—
—
0
0
29
215
1.36
0.81
1.3
1.5
—
—
—
0
0
112
974
1.17
0.81
3.7
3.9
3.74
25.10
ug/l
1.85
84
824
0
25
0.00
0.79
0.0
1.2
—
0.29
—
0
20
0
26
0.00
0.78
0.0
1.2
—
110.81
—
0
21
263
2427
1.11
0.78
4.2
4.8
23.25
21.61
%
1.01
128
1269
16
107
1.50
0.76
1.3
1.4
—
—
—
0
0
16
107
1.50
0.76
1.3
1.4
—
—
—
0
0
16
107
1.50
0.76
1.3
1.4
—
—
—
0
0
22
301
0.72
0.75
1.4
1.7
—
—
—
0
0
13
83
1.57
0.75
2.2
2.3
1.20
2.13
u/field
—
5
23
25
334
0.74
0.74
1.5
1.9
—
—
—
0
0
24
176
1.37
0.73
2.0
1.7
—
—
—
0
0
27
202
1.35
0.73
4.7
2.4
15.28
15.43
%
0.08
20
97
27
203
1.34
0.71
1.3
1.6
—
—
—
0
0
7
42
1.67
0.68
1.0
1.1
—
—
—
0
0
9
59
1.53
0.68
1.4
1.0
—
—
—
0
0
7
43
1.63
0.67
1.4
1.2
—
—
—
0
0
7
43
1.63
0.67
1.4
1.2
—
—
—
0
0
8
50
1.60
0.61
1.9
1.5
—
—
—
0
0
15
105
1.44
0.60
3.0
3.6
—
—
—
0
0
27
210
1.29
0.59
1.4
1.7
14650.75
18263.41
e6/l
0.27
20
152
19
140
1.36
0.58
1.1
1.5
—
—
—
0
0
19
140
1.36
0.58
1.1
1.5
—
—
—
0
0
13
89
1.47
0.58
1.1
1.4
—
—
—
0
0
13
89
1.47
0.58
1.1
1.4
—
—
—
0
0
20
149
1.35
0.58
1.4
1.4
—
—
—
0
0
15
106
1.42
0.58
3.9
4.4
294.60
361.65
umol/l
—
10
94
17
124
1.38
0.56
1.5
1.5
—
—
—
0
0
21
159
1.33
0.55
1.4
1.6
—
—
—
0
0
15
107
1.41
0.55
1.4
1.5
—
—
—
0
0
15
107
1.41
0.55
1.3
1.4
—
—
—
0
0
18
133
1.36
0.55
1.5
1.4
—
—
—
0
0
12
82
1.47
0.54
1.2
1.2
—
—
—
0
0
9
61
1.48
0.53
1.8
1.4
—
—
—
0
0
15
108
1.39
0.53
1.3
1.4
—
—
—
0
0
6
39
1.54
0.53
1.0
1.3
—
—
—
0
0
31
250
1.25
0.53
1.3
1.4
—
—
—
0
0
6
40
1.50
0.51
1.2
1.5
—
—
—
0
0
24
188
1.28
0.51
1.8
1.6
—
—
—
0
0
16
119
1.35
0.48
1.5
1.5
—
—
—
0
0
11
77
1.43
0.45
1.7
1.5
—
—
—
0
0
18
138
1.31
0.45
1.2
1.4
—
—
—
0
0
12
86
1.40
0.44
1.1
1.8
—
—
—
0
0
5
32
1.57
0.42
1.2
3.2
—
—
—
0
0
5
32
1.57
0.42
1.0
1.3
—
—
—
0
0
5
32
1.57
0.42
1.2
3.2
—
—
—
0
0
16
123
1.31
0.40
1.5
1.5
409.44
293.41
mu/l
0.74
16
111
18
141
1.28
0.40
1.2
1.3
—
—
—
0
0
182
1709
1.08
0.40
2.8
3.3
1.02
0.80
ug/l
0.46
125
1193
13
97
1.34
0.39
1.1
1.0
—
—
—
0
0
5
35
1.43
0.39
1.0
1.1
—
—
—
0
0
5
35
1.43
0.39
2.6
1.4
—
—
—
0
0
5
37
1.35
0.37
1.0
1.8
—
—
—
0
0
5
37
1.35
0.37
1.0
1.8
—
—
—
0
0
28
235
1.20
0.36
1.1
1.2
—
—
—
0
0
9
126
0.71
0.35
1.1
1.1
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
45
1.34
0.33
1.0
1.2
—
—
—
0
0
36
312
1.16
0.33
1.2
1.3
—
—
—
0
0
15
119
1.26
0.32
1.5
1.5
—
—
—
0
0
26
305
0.85
0.31
1.0
1.0
—
—
—
0
0
30
346
0.86
0.30
1.5
1.7
—
—
—
0
0
30
346
0.86
0.30
2.8
3.5
141.97
69.02
u/ml
0.25
30
333
18
148
1.22
0.29
1.8
1.4
1203.25
1344.96
e6/l
0.08
12
106
27
233
1.16
0.27
1.1
1.2
—
—
—
0
0
23
196
1.18
0.27
1.8
2.2
95.35
87.98
%
0.99
23
187
15
124
1.21
0.24
1.0
1.1
—
—
—
0
0
5
38
1.32
0.23
1.0
1.8
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
12
98
1.23
0.21
1.8
2.7
—
—
—
0
0
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
10
80
1.25
0.20
1.1
1.4
6880.00
139364.62
e6/l
—
5
53
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
6
51
1.18
0.19
1.0
1.6
—
—
—
0
0
6
51
1.18
0.19
1.0
1.6
—
—
—
0
0
21
184
1.14
0.19
1.5
1.5
—
—
—
0
0
18
156
1.16
0.18
1.0
1.1
—
—
—
0
0
7
61
1.15
0.17
1.0
1.0
—
—
—
0
0
8
70
1.14
0.16
1.5
1.2
—
—
—
0
0
8
70
1.14
0.16
1.0
1.1
—
—
—
0
0
9
81
1.11
0.15
1.1
1.8
—
—
—
0
0
116
1116
1.04
0.15
1.3
1.2
5.85
14.34
u/ml
1.54
49
379
9
82
1.10
0.15
1.0
1.6
—
—
—
0
0
9
82
1.10
0.15
1.0
1.6
—
—
—
0
0
9
82
1.10
0.15
1.0
1.6
—
—
—
0
0
107
1028
1.05
0.14
4.8
4.8
34.16
32.94
%
0.44
61
657
7
89
0.79
0.14
1.0
1.0
—
—
—
0
0
15
131
1.15
0.14
1.6
1.4
28896.33
83141.43
e6/l
—
6
77
10
117
0.85
0.13
1.5
1.9
—
—
—
0
0
5
64
0.78
0.08
3.2
2.1
—
—
—
0
0
8
74
1.08
0.07
1.1
1.6
—
—
—
0
0
8
75
1.07
0.07
1.0
1.1
—
—
—
0
0
11
100
1.10
0.05
1.9
2.0
200.18
211.46
pmol/l
0.11
11
92
203
2007
1.01
0.05
1.8
1.6
1.34
1.31
mmol/l
0.22
185
1642
35
359
0.97
0.02
1.2
1.2
143.15
138.56
iu/ml
0.01
13
135
14
147
0.95
0.01
1.4
2.0
—
—
—
0
0
20
193
1.04
0.01
5.9
4.0
27.08
27.41
mg/l
0.01
13
128
11
114
0.96
0.00
1.2
1.5
—
—
—
0
0
19
191
0.99
0.00
1.2
1.3
—
—
—
0
0
5
56
0.89
0.00
1.6
1.1
—
—
—
0
0
5
53
0.94
-0.00
1.6
1.4
—
—
—
0
0
8
84
0.95
-0.00
1.8
1.3
—
—
—
0
0
8
86
0.93
-0.00
1.4
1.4
—
—
—
0
0
18
180
1.00
-0.00
1.2
1.7
3.23
2.46
mg/l
0.20
13
141
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
-0.00
0.0
3.0
—
0.63
—
0
8
0
7
0.00
-0.00
0.0
1.6
—
11.86
—
0
7
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.8
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: L12_PEMPHIGOID – Pemphigoid
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).